Page last updated: 2024-08-23

staurosporine and tanespimycin

staurosporine has been researched along with tanespimycin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dent, P; Grant, S; Jia, W; Krystal, G; Rahmani, M; Sausville, EA; Yu, C	1
Annavarapu, S; Bali, P; Bhalla, K; Cohen, P; Fiskus, W; George, P; Guo, F; Moscinski, L; Scuto, A; Sigua, C; Tao, J; Vishvanath, A	1

Other Studies

2 other study(ies) available for staurosporine and tanespimycin

Article	Year
Synergistic antileukemic interactions between 17-AAG and UCN-01 involve interruption of RAF/MEK- and AKT-related pathways. Blood, 2003, Sep-01, Volume: 102, Issue:5 Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Benzoquinones; Caspases; Drug Synergism; HL-60 Cells; Humans; Jurkat Cells; Lactams, Macrocyclic; Leukemia; MAP Kinase Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-raf; Rifabutin; Staurosporine; U937 Cells	2003
Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3. Cancer research, 2004, May-15, Volume: 64, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Cysteine Endopeptidases; DNA-Binding Proteins; DNA, Neoplasm; Drug Synergism; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; G1 Phase; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Leukemia, Myeloid, Acute; Milk Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Multienzyme Complexes; Proteasome Endopeptidase Complex; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor Protein-Tyrosine Kinases; Rifabutin; Signal Transduction; STAT5 Transcription Factor; Staurosporine; Trans-Activators; Ubiquitin	2004

Article

Year

Synergistic antileukemic interactions between 17-AAG and UCN-01 involve interruption of RAF/MEK- and AKT-related pathways.

Blood, 2003, Sep-01, Volume: 102, Issue:5

Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Benzoquinones; Caspases; Drug Synergism; HL-60 Cells; Humans; Jurkat Cells; Lactams, Macrocyclic; Leukemia; MAP Kinase Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-raf; Rifabutin; Staurosporine; U937 Cells

2003

Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3.

Cancer research, 2004, May-15, Volume: 64, Issue:10

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Cysteine Endopeptidases; DNA-Binding Proteins; DNA, Neoplasm; Drug Synergism; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; G1 Phase; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Leukemia, Myeloid, Acute; Milk Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Multienzyme Complexes; Proteasome Endopeptidase Complex; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor Protein-Tyrosine Kinases; Rifabutin; Signal Transduction; STAT5 Transcription Factor; Staurosporine; Trans-Activators; Ubiquitin

2004